Variations in clinicopathologic characteristics of thyroid cancer among racial ethnic groups: analysis of a large public city hospital and the SEER database



      Clinicopathologic variables influence the treatment and prognosis of patients with thyroid cancer.


      A retrospective analysis of public hospital thyroid cancer database and the Surveillance, Epidemiology and End Results 17 database was conducted. Demographic, clinical, and pathologic data were compared across ethnic groups.


      Within the public hospital database, Hispanics versus non-Hispanic whites were younger and had more lymph node involvement (34% vs 17%, P < .001). Median tumor size was not statistically different across ethnic groups. Similar findings were demonstrated within the Surveillance, Epidemiology and End Results database. African Americans aged <45 years had the largest tumors but were least likely to have lymph node involvement. Asians had the most stage IV disease despite having no differences in tumor size, lymph node involvement, and capsular invasion.


      There is considerable variability in the clinical presentation of thyroid cancer across ethnic groups. Such disparities persist within an equal-access health care system. These findings suggest that factors beyond socioeconomics may contribute to such differences.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. American Cancer Society. Leading new cancer cases—2012 estimates. Available at: Accessed August 19, 2012.

        • Grodski S.
        • Brown T.
        • Sidhu S.
        • et al.
        Increasing incidence of thyroid cancer is due to increased pathologic detection.
        Surgery. 2008; 144: 1038-1043
        • Hall S.F.
        • Walker H.
        • Siemens R.
        • et al.
        Increasing detection and increasing incidence of thyroid cancer.
        World J Surg. 2009; 33: 2567-2571
        • Davies L.
        • Welch H.G.
        Increasing incidence of thyroid cancer in the United States 1973-2002.
        JAMA. 2006; 295: 2164-2167
        • Cramer J.D.
        • Fu P.
        • Harth K.C.
        • et al.
        Analysis of the rising incidence of thyroid cancer using the Surveillance, Epidemiology and End Results national cancer registry.
        Surgery. 2010; 148: 1147-1152
        • Morris L.
        • Myssiorek D.
        Improved detection does not fully explain the rising incidence of well-differentiated thyroid cancer: a population-based analysis.
        Am J Surg. 2010; 200: 454-461
        • Yu G.
        • Chun-Lun Li J.
        • Branovan D.
        • et al.
        Thyroid cancer incidence and survival in the National Cancer Institute Surveillance, Epidemiology and End Results race/ethnicity groups.
        Thyroid. 2010; 20: 465-473
        • Bilimoria K.Y.
        • Bentrem D.J.
        • Linn J.G.
        • et al.
        Utilization of total thyroidectomy for papillary thyroid cancer in the United States.
        Surgery. 2007; 142: 906-913
        • Hollenbeak C.S.
        • Wang L.
        • Schneider P.
        • et al.
        Outcomes of thyroid cancer in African-Americans.
        Ethn Dis. 2011; 21: 210-215
        • Mohammed S.I.
        • Springfield S.
        • Das R.
        Role of epigenetics in cancer health disparities.
        Methods Mol Biol. 2012; 863: 395-410
        • Henderson B.E.
        • Lee N.H.
        • Seewaldt V.
        • et al.
        The influence of race and ethnicity on the biology of cancer.
        Nat Rev Cancer. 2012; 12: 648-654
        • Kim H.G.
        • Kim N.K.
        • Choi J.H.
        • et al.
        Associations between body mass index and clinico-pathological characteristics of papillary thyroid cancer.
        Clinc Endocrinol. 2013; 78: 134-140
      2. National Cancer Institute. SEER registry groupings for analyses. Available at: Accessed August 18, 2012.

        • Mazzaferri E.L.
        • Jhiang S.M.
        Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.
        Am J Med. 1994; 97: 418-428
        • Greene F.L.
        American Joint Committee on Cancer staging manual.
        6th ed. Springer-Verlag, New York2002
        • Machens A.
        • Holzhausen H.J.
        • Dralle H.
        The prognostic value of primary tumor size in papillary and follicular carcinoma.
        Cancer. 2005; 103: 2269-2273
        • Roti E.
        • Rossi R.
        • Trasforini G.
        • et al.
        Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients.
        J Clin Endocrinol Metab. 2006; 91: 2171-2178
        • Mirallie E.
        • Sagan C.
        • Hamy A.
        • et al.
        Predictive factors for node involvement in papillary thyroid carcinoma. Univariate and multivariate analyses.
        Eur J Cancer. 1999; 35: 420-423
        • Zhang L.
        • Wen-jun W.
        • Qinig-hai J.
        • et al.
        Risk factors for neck nodal metastasis in papillary thyroid microcarcinoma: a study of 1066 patients.
        J Clin Endocrinol Metab. 2012; 97: 1250-1257
      3. National Cancer Institute. Population characteristics. National Cancer Institute Surveillance Epidemiology and End Results. Available at: Accessed September 24, 2012.

        • Freedman M.L.
        • Haiman C.A.
        • Patterson N.
        • et al.
        Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men.
        Proc Natl Acad Sci USA. 2006; 103: 14068-14073
        • Kazaure H.S.
        • Roman S.A.
        • Sosa J.A.
        Aggressive variants of papillary thyroid cancer: incidence, characteristics and predictors of survival among 43,738 patients.
        Ann Surg Oncol. 2012; 19: 1874-1880